Rachael A. Safyan

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with University of Washington, Fred Hutch Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)”.

S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

Future Oncology(2025)10.1080/14796694.2025.2485020

N/A

0.176DataRank · unranked

2 citations

Sarah Colby, Paul E. Oberstein, Dan G. Duda, Robin Park, Rajiv Agarwal +12 more

HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2200

N/A

0DataRank · unranked

8 citations

Stephanie Dobersch, Ian M. Loveless, Annie N. Samraj, Gun Ho Jang, Miki Haraguchi +17 more